| Methods |
RCT with 3 groups: PRT, control, and aerobic group
Method of randomisation: not reported
Assessor blinding: not reported
Participant blinding: not reported
Loss to follow‐up: 0
Intention‐to‐treat analysis: N/A
Post‐program follow‐up: no |
| Participants |
Location: USA
N = 30 (15 in each group)
Sample: highly active and functioning women
Age: mean 73 years (SD = 3)
Inclusion criteria: not reported
Exclusion criteria: dementia screened by MMSE, did not meet the criteria of the American College of Sports Medicine, the presence of activity‐limiting arthritis; being bedridden within 3 months of the study; the presence of central or peripheral nervous system disorders, stroke, acute or chronic infection, major affective disorder, human immunodeficiency virus infection or autoimmune disorders, or metabolic disorders (type I diabetes mellitus); being a smoker or smokeless tobacco user; participating in regular aerobic or resistance training within the previous 3 months; using oral steroids or medications known to have an effect on blood lipids except hormone replacement therapy; having surgery within the previous 3 months; and consuming caffeine in excess of the equivalent of 4 cups of coffee per day. |
| Interventions |
PRT versus control and aerobic
1. PRT
Type of Ex: 7 LL
Equipment: not reported
Intensity: 8RM
Frequency: Ex3
Reps/Sets: 8/3
Duration: 10 weeks
Setting: not reported
Supervision: not reported
Adherence: > 95 %
2. Control Group: maintain normal activity level
3. Aerobic training group: stretching and walking exercise at 70% heart rate reserve, duration increased from 20 minutes to 30 minutes through out the program |
| Outcomes |
Muscle strength (1RM)
1‐minet walk (no data available for the PRT group)
VO2 max
Comments on adverse events: no |
| Notes |
Comparisions: PRT versus control, and PRT versus aerobic |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Allocation concealment? |
Unclear risk |
B ‐ Unclear |
